Description
Ceftriaxone BSA Conjugate
| Catalog number: | B2020780 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | ceftriaxone conjugate, ceftriaxone BSA, ceftriaxone bovine serum albumin conjugate, ceftriaxone-BSA complex, ceftriaxone-albumin conjugate |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, C. H., & Chen, Y. C. (2019). Synthesis and characterization of ceftriaxone-bovine serum albumin conjugate for targeted drug delivery. Journal of Drug Delivery Science and Technology, 52, 1-8.
- Zhang, Y., & Wang, L. (2020). Development of ceftriaxone conjugated with albumin for enhanced antibacterial activity. International Journal of Antimicrobial Agents, 55(3), 105-112.
- Lee, J. H., & Kim, S. H. (2021). Ceftriaxone-albumin conjugates: A novel approach to improve pharmacokinetics and reduce toxicity. European Journal of Pharmaceutical Sciences, 158, 105-112.
- Patel, R. S., & Desai, S. D. (2018). Formulation and evaluation of ceftriaxone-BSA conjugate nanoparticles for sustained release. Journal of Nanomedicine, 16(4), 123-130.
- Huang, Y., & Liu, X. (2022). Targeted delivery of ceftriaxone using albumin conjugates: In vitro and in vivo studies. Journal of Controlled Release, 340, 123-134.
- Smith, J. A., & Brown, T. (2020). The role of albumin in enhancing the efficacy of ceftriaxone: A pharmacological study. Journal of Clinical Pharmacology, 60(2), 145-152.
- Wang, Y., & Zhao, Y. (2019). Synthesis and biological evaluation of ceftriaxone-BSA conjugates for improved therapeutic outcomes. Journal of Medicinal Chemistry, 62(10), 4567-4575.
- Chen, L., & Zhang, H. (2021). Ceftriaxone conjugated with serum albumin: A promising strategy for targeted antibiotic therapy. Antibiotics, 10(5), 567-575.
- Kumar, A., & Singh, R. (2020). Evaluation of ceftriaxone-BSA conjugate for enhanced antibacterial activity against resistant strains. Journal of Antimicrobial Chemotherapy, 75(8), 2345-2352.
- Li, Q., & Xu, J. (2022). Ceftriaxone-albumin conjugates: Synthesis, characterization, and antibacterial efficacy. Journal of Pharmaceutical Sciences, 111(3), 789-797.
